Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mobile Lung Cancer Screening
Sponsor: Hospices Civils de Lyon
Summary
Lung cancer screening using low-dose CT (LDCT) has been shown to reduce mortality in high-risk populations. In 2022, the French National Cancer Institute (INCa) issued guidelines recommending screening for individuals aged 50-74 with a history of heavy smoking, including current smokers or those who quit less than 15 years ago. A national pilot program (IMPULSION) will be launched in 2025. Lung cancer incidence is strongly correlated with socioeconomic status, yet underserved populations remain difficult to engage in screening programs. Mobile health units using a "reach-out" strategy have demonstrated effectiveness in other countries (UK, Brazil, USA). In France, this approach has been used for breast cancer screening via mobile mammography units. The MobILYAD project aims to compare two screening modalities- a mobile demedicalized unit (CT-equipped van with trained nurses) and a conventional hospital-based unit- to assess the effectiveness of mobile screening in reaching socially disadvantaged populations.
Official title: Lyon Initiative for the Mobile Demedicalized Initiation of Lung Cancer Screening
Key Details
Gender
All
Age Range
50 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
4312
Start Date
2025-06-12
Completion Date
2028-09
Last Updated
2025-09-09
Healthy Volunteers
Yes
Conditions
Interventions
Low-dose Chest CT Screening
Participants undergo a low-dose chest CT scan to screen for early lung cancer and assess associated conditions (emphysema, coronary calcifications, osteoporosis).
Spirometry
Assessment of lung function through spirometry, with optional plethysmography and diffusion testing to detect COPD and PRISM patterns.
Cardiovascular Risk Assessment
Cardiovascular risk is evaluated using SCORE2/SCORE2-OP tools, based on blood pressure and cholesterol levels.
Smoking Cessation Support
Active smokers receive a structured smoking cessation intervention, including a baseline consultation and up to two follow-up sessions (which may be remote).
Optional Biospecimen Collection (Bio-ILYAD)
Optional collection of blood and exhaled breath condensate for future analysis of biomarkers in lung cancer detection.
Locations (2)
" Centre de dépistage mobile " - Hôpital Lyon Sud
Pierre-Bénite, France
Service de Pneumologie " Centre de dépistage non mobile " - Hôpital Lyon Sud
Pierre-Bénite, France